Evidence map›Paper›PMID 40598087›Full record

ArticleBMC biotechnology2025

A simplified two-plasmid system for orthogonal control of mammalian gene expression using light-activated CRISPR effector.

Shruthi S Garimella, Shiaki A Minami, Anusha N Khanchandani, Justin C Abad Santos, Susannah R Schaffer, Priya S Shah

Abstract read
In one paragraph

Article in BMC biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shruthi S GarimellaDepartment of Chemical Engineering, University of California, Davis, USA.ORCID 0009-0006-0655-2094
Shiaki A MinamiDepartment of Chemical Engineering, University of California, Davis, USA.ORCID 0000-0003-1468-9542
Anusha N KhanchandaniDepartment of Chemical Engineering, University of California, Davis, USA.
Justin C Abad SantosDepartment of Chemical Engineering, University of California, Davis, USA.ORCID 0009-0009-4153-6462
Susannah R SchafferDepartment of Chemical Engineering, University of California, Davis, USA.
Priya S ShahDepartment of Chemical Engineering, University of California, Davis, USA. prsshah@ucdavis.edu.ORCID 0000-0001-7518-2839

Funding

AMPAC Fine Chemicals Summer Research Internship n/aGood Food Institute n/aHellman Family Foundation n/a
6 · The paper itself

Abstract

backgroundOptogenetic systems use light-responsive proteins to control gene expression, ion channels, protein localization, and signaling with the "flip of a switch". One such tool is the light activated CRISPR effector (LACE) system. Its ability to regulate gene expression in a tunable, reversible, and spatially resolved manner makes it attractive for many applications. However, LACE relies on delivery of four separate components on individual plasmids, which can limit its use. Here, we optimize LACE to reduce the number of plasmids needed to deliver all four components.

resultsThe two-plasmid LACE (2pLACE) system combines the four components of the original LACE system into two plasmids. Following construction, the behavior of 2pLACE was rigorously tested using optogenetic control of enhanced green fluorescent protein (eGFP) expression as a reporter. Using human HEK293T cells, we optimized the ratio of the two plasmids, measured activation as a function of light intensity, and determined the frequency of the light to activate the maximum fluorescence. Overall, the 2pLACE system showed a similar dynamic range, tunability, and activation kinetics as the original four plasmid LACE (4pLACE) system. Interestingly, 2pLACE also had less variability in activation signal compared to 4pLACE. We also demonstrate the optimal LACE system also depends on cell type. In mouse myoblast C2C12 cells, 2pLACE displayed less variability compared to 4pLACE, similar to HEK293T cells. However, 2pLACE also had a smaller dynamic range in C2C12 cells compared to 4pLACE.

conclusionsThis simplified system for optogenetics will be more amenable to biotechnology applications where variability needs to be minimized. By optimizing the LACE system to use fewer plasmids, 2pLACE becomes a flexible tool in multiple research applications. However, the optimal system may depend on cell type and application.

Indexed as

CRISPR-Cas SystemsGene Expression RegulationOptogeneticsPlasmidsAnimalsClustered Regularly Interspaced Short Palindromic RepeatsGene ExpressionGreen Fluorescent ProteinsHEK293 CellsHumansLightenhanced green fluorescent proteinGreen Fluorescent ProteinsCotransfectionCRISPRCRY2-CIBNEmbryonic kidney cellsFlow cytometryMyoblastsOptogenetics

Identifiers

PMID40598087
PMCPMC12220775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.